|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Nephropathies | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Kidney Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Diabetes Complications | |||||
| Diabetes Mellitus | |||||
| Endocrine System Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Folic Acid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Growth Substances | |||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Erlangen-Nürnberg | |||||